Free Trial

Nemaura Medical (NMRD) News Today

Nemaura Medical logo
$0.0003
0.00 (0.00%)
(As of 11/1/2024 ET)
Nemaura Medical Inc (NMRD)
NXNN Nexeon Medsystems Inc
Acutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2M
Nemaura Medical Announces SFDA Approval of sugarBEAT®
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
Nemaura Medical (NASDAQ: NMRD)
Get Nemaura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.

Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).

NMRD Media Mentions By Week

NMRD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NMRD
News Sentiment

0.00

0.45

Average
Medical
News Sentiment

NMRD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NMRD Articles
This Week

0

0

NMRD Articles
Average Week

Get Nemaura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NMRD) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners